- Home
- CELU vs CATO Comparison
CELU vs CATO Comparison
Compare CELU & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CELU | CATO |
|---|---|---|
| Founded | 2016 | 1946 |
| Country | United States | United States |
| Employees | 123 | 7000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1M | 60.0M |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | CELU | CATO |
|---|---|---|
| Price | $1.22 | $2.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 92.9K | 49.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.09 |
| EPS | N/A | ★ 0.25 |
| Revenue | N/A | ★ $649,806,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $76.00 | N/A |
| P/E Ratio | ★ N/A | $12.16 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.01 | $2.19 |
| 52 Week High | $4.35 | $4.92 |
Technical Indicators
Market Signals| Indicator | CELU | CATO |
|---|---|---|
| Relative Strength Index (RSI) | 46.65 | 45.19 |
| Support Level | $1.21 | $2.81 |
| Resistance Level | $1.33 | $3.22 |
| Average True Range (ATR) | 0.12 | 0.18 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 44.43 | 17.31 |
Price Performance
Historical ComparisonAbout CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
About CATO Cato Corporation (The)
The Cato Corp operates as a specialty retailer of fashion apparel and accessories in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.